Navigation Links
Results of Linjeta™ Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting
Date:9/21/2010

DANBURY, Conn., Sept. 21 /PRNewswire/ -- In a platform presentation at the 46th annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, investigators for Biodel Inc. (Nasdaq: BIOD) today presented the results of a clinical study evaluating a new pH-neutral formulation of Linjeta™ (VIAject®).   Dr. Tim Heise (Profil Institute for Metabolic Research, Neuss, Germany) and colleagues reported that the new pH-neutral, 100 IU/ml formulation of Linjeta™ was bioequivalent to the previously studied pH-4, 25 IU/ml formulation of Linjeta™, and had faster absorption and onset of action than insulin lispro.  These findings were also presented by Dr. Heise in June at the 70th scientific sessions of the American Diabetes Association in Orlando, Florida.

Linjeta™ is Biodel's more-ultra-rapid-acting insulin formulation that is currently under review by the U.S. Food and Drug Administration.  The purpose of this study was to demonstrate the bioequivalence of the two formulations of Linjeta™, compare the pharmacokinetic and pharmacodynamic characteristics of pH-neutral, 100 IU/ml Linjeta™ and insulin lispro in 43 patients with Type 1 diabetes.  The trial was conducted as a randomized, double-blind crossover study.  There were no serious adverse events or discontinuations because of treatment-emergent adverse events; headache was the most frequent adverse event reported (8 patients).  Additional studies are planned to evaluate the impact of Linjeta™ on glucose control.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes. Biodel's product candidates are developed using VIAdel™ technology, which reformulates existing FDA-approved peptide drugs.  Biodel's new d
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
2. Dynatronics to Release Fourth Quarter and Year-End Results Wednesday, September 22, 2010; Conference Call Set for 1:00 p.m. ET
3. LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results
4. Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
5. Corgenix to Host Conference Call to Discuss Fiscal 2010 Results
6. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
7. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
8. Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Streamline Health® Solutions Reports Q2 Results
11. ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmins Potential to Transform the Treatment of Retinal Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 LSI Medience ... an Agreement with Kineticos, a Raleigh-Durham, ... Kineticos will support LSI Medience in identifying opportunities ... to demonstrate utility in clinical trials. ... utility in diagnosis of sepsis, prognosis of septic ...
(Date:7/24/2014)... , July 24, 2014  Lazarus Effect, ... of novel interventional devices to facilitate removal of ... Patent and Trademark Office has issued a new ... behind the company,s Lazarus Cover TM and ... Lazarus ReCover is a single-component stent-retriever (stentriever) with ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- "North America Orthopedic Braces ... data on the North America Orthopedic Braces and Supports ... dollars, and volume (in units) and average price data ... Knee Braces and Supports , Ankle Braces and ... Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... , POTOMAC FALLS, Va., Nov. 9 TessArae® ... announces the launch of new integrated product solutions ... human hereditary diseases. The combination of TessArae,s ... basecalling algorithms and analysis software enables screening for ...
... /PRNewswire/ -- On Sept. 11, 2001, thousands of ... save as many lives as possible in New York City. ... responders. Now he is fighting to save his own life. ... cancer in 2006. He has undergone surgery and extensive chemotherapy ...
Cached Medicine Technology:TessArae Delivers Lower Cost Option to Genetic Testing Market 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3
(Date:7/24/2014)... July 24, 2014 (HealthDay News) -- Drinking caffeine may ... roughly two-thirds of women as they go through menopause, ... preliminary, our study suggests that limiting caffeine intake may ... hot flashes and night sweats," said researcher Dr. Stephanie ... Mayo Clinic in Rochester, Minn. But caffeine -- ...
(Date:7/24/2014)... Hospital and the University of Tennessee Health Science Center ... drug shown to safely reduce the viral load and ... respiratory syncytial virus (RSV). RSV is the most common ... in the United States and worldwide. , The ... John DeVincenzo, MD. DeVincenzo,s Le Bonheur lab has been ...
(Date:7/24/2014)... As the age of marriage and childbirth ... a way to ensure future family building options by ... reproductive age. Vitrification technology, a fast freeze method for ... that allows a woman to have multiple eggs retrieved ... are then stored for future use. When circumstances allow, ...
(Date:7/24/2014)... 24, 2014 In a recent report by ... officially put an end to criminal penalties associated with possession ... era for marijuana reform in Washington DC, giving it one ... law replaces criminal penalties for possession of one ounce of ... the possession of more than an ounce of marijuana remain ...
(Date:7/24/2014)... PROVIDENCE, R.I. Lynn E. Taylor, M.D., director ... states in the July, 2014 Rhode Island ... C" that eliminating hepatitis c virus infection (hep ... benefits, enhance capacity to address other health challenges, ... HCV in the United States, Taylor says, include ...
Breaking Medicine News(10 mins):Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:RSV research breakthrough to help infected children 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Washington D.C. Decriminalizes Marijuana 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 3Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 4
... Nov. 6 Those biopharmaceutical companies that are ... their business models will be best positioned to ... according to a white paper published today by ... equity firm, and Health Advances, a leading healthcare ...
... 6 Bulletproof Blog , the ... with former Speaker of the U.S. House of Representatives ... to effect America,s business landscape. , In the interview, ... impacting the crossroads of business and government, including healthcare ...
... Nov. 6 Allied World Assurance,Company Holdings, Ltd ... World U.S.,Nicole Baummer, Assistant Vice President for Private/Not-for-Profit ... Lines,Claims, will be speaking at this year,s Professional ... in Chicago, Illinois,November 11-13, 2009. , ...
... 6 We Work for Health, an alliance of ... released the results of a first-of-its-kind economic impact study ... passed many of the traditional resource-based industries on which ... same range of importance as some of the new, ...
... Nov. 6 The current health care debate in the ... choices and life expectancy have been suggested but seldom clearly ... year on health care for every 80 year old, while ... octogenarians have a 20 percent less chance of dying than ...
... food choices in study , FRIDAY, Nov. 6 (HealthDay News) ... choices, researchers say. , The new study included 542 male ... irregular shifts. The average age of the participants was 49, ... sleep medicine division at Harvard Medical School found that adequate ...
Cached Medicine News:Health News:Surviving Healthcare Reform: How Biopharma Companies Can Come Out on Top 2Health News:Former House Speaker Newt Gingrich Shares Insights on Healthcare Reform and the Federal Pay Czar with BulletproofBlog.com 2Health News:Allied World's Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference 2Health News:Allied World's Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference 3Health News:New Study: Life Science Jobs Total 77,000 in Washington State 2Health News:New Study: Life Science Jobs Total 77,000 in Washington State 3Health News:Carnegie Mellon Researcher Links Health Care Debate to Risk of Dying in the U.S. and Europe 2Health News:Carnegie Mellon Researcher Links Health Care Debate to Risk of Dying in the U.S. and Europe 3Health News:Carnegie Mellon Researcher Links Health Care Debate to Risk of Dying in the U.S. and Europe 4
Steroid-eluting, screw-in pacing lead...
... one of the world's thinnest, ... a 7 F introducer, the ... designed to lower the incidence ... introduction in smaller, more tortuous ...
... Vitatron Crystalline Active fixation lead series ... new extendable retractable helix mechanism, specifically ... the pacemaker system, reducing the sensing ... The Crystalline Active fixation leads allow ...
... 6491 unipolar pediatric temporary pacing ... atrial and ventricular sensing and ... surgery. This temporary pacing lead ... the ideal lead for pediatric ...
Medicine Products: